Fuji Film Establishes Research Institute To Strengthen Pharmaceutical R&D
This article was originally published in PharmAsia News
Executive SummaryFuji Film established June 26 a pharmaceutical research Institute to strengthen research and development in new drug discovery. Located inside the company's advanced research institute in Kanagawa Prefecture, the facility will focus on cancer drugs and drug delivery systems. Since Film acquired Toyama Chemical, the company has consolidated research staff and concentrated in pharmaceutical R&D activities. (Click here for more - Japanese language
You may also be interested in...
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced January 2020.
Industry experts expect a continued uptick in deals valued between $2bn-$10bn this year as buyers look to add critical mass in areas like oncology, rare disease and cell and gene therapy. Divestitures to free up capital and narrow focus should continue too.
UK-centric investment firm Syncona’s model of “founding, building and funding” early-stage biotech companies – with a commitment to the longer term – hopes to help make Great Britain a cell and gene therapy powerhouse.